过去一年中添加的文章，按日期排序
[引用][C] P42-5 Efficacy and safety of camrelizumab and carboplatin and pemetrexed in advanced nonsquamous NSCLC: A systematic review
JIX Hasan, P Yossy, EW Mokalu… - Annals of …, 2024 - annalsofoncology.org
42 天前 - … efficacy and safety of pembrolizumab and chemotherapy as first-line treatments for
Non-Small Cell Lung Cancer … -1/PD-L1 monoclonal antibodies or apatinib. The quality of the …
Non-Small Cell Lung Cancer … -1/PD-L1 monoclonal antibodies or apatinib. The quality of the …
EP. 12A. 02 What is the Optimal First-Line Regimen for EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis
W Zhang, Z Guo, L Ye, Z Chen, K Xu, X Liu, Y Liu… - Journal of Thoracic …, 2024 - jto.org
42 天前 - … the efficacy and safety of distinct regimens to determine the optimal regimen for
patients … , amivantamab plus lazertinib and aumolertinib plus apatinib) could be the new and …
patients … , amivantamab plus lazertinib and aumolertinib plus apatinib) could be the new and …
The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer
X Wei, Y Zhao, W Yan, Q Dai, H Wu, Y Miao… - OncoTargets and …, 2024 - Taylor & Francis
98 天前 - … examining apatinib and anlotinib in clinical settings. Our objective was to compare
their efficacy and safety, as well as to delineate any differences in the treatment of advanced …
their efficacy and safety, as well as to delineate any differences in the treatment of advanced …
[HTML][HTML] Immunotherapy unleashed: pioneering chemo-free neoadjuvant programmed cell death ligand 1 (PD-L1) inhibition for resectable non-small cell lung cancer …
NE Rossetti, V Puri - AME Clinical Trials Review, 2024 - actr.amegroups.org
235 天前 - … Camrelizumab and apatinib have been studied most widely in the treatment of
hepatocellular carcinoma (15) and have demonstrated efficacy in the treatment of several other …
hepatocellular carcinoma (15) and have demonstrated efficacy in the treatment of several other …
Efficacy and safety of apatinib plus chemotherapy vs. chemotherapy alone for the treatment of advanced‑stage non‑small cell lung cancer: A meta‑analysis
S Qin, X Han, Z Li - Oncology Letters, 2023 - spandidos-publications.com
360 天前 - … its use in non‑small cell lung cancer (NSCLC) … efficacy and safety of the use of
apatinib plus chemotherapy vs. chemotherapy alone for the treatment of patients with advanced‑…
apatinib plus chemotherapy vs. chemotherapy alone for the treatment of patients with advanced‑…